Cargando…
Immunomodulatory Therapy Reduces the Severity of Placental Lesions in Chronic Histiocytic Intervillositis
Chronic histiocytic intervillositis (CHI) is a rare, but highly recurrent inflammatory placental lesion wherein maternal macrophages infiltrate the intervillous space. Pregnancies with CHI are at high risk of fetal growth restriction, miscarriage or stillbirth. Presently, the diagnosis can only be m...
Autores principales: | Brady, Chloe A., Williams, Charlotte, Batra, Gauri, Church, Elaine, Tower, Clare L., Crocker, Ian P., Heazell, Alexander E. P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558526/ https://www.ncbi.nlm.nih.gov/pubmed/34733868 http://dx.doi.org/10.3389/fmed.2021.753220 |
Ejemplares similares
-
Chronic histiocytic intervillositis: A breakdown in immune tolerance comparable to allograft rejection?
por: Brady, Chloe A., et al.
Publicado: (2020) -
C4d Staining Is Present in Normal Placentas From Pregnancies Prior to Pregnancy Loss Associated With Chronic Histiocytic Intervillositis and Is Reduced by Immunomodulatory Therapy in Subsequent Pregnancies
por: Chan, Elaine S., et al.
Publicado: (2023) -
The Missing Role of Prenatal Diagnosis of Chronic Histiocytic Intervillositis in the Management of Growth Restricted Fetuses
por: Hantoushzadeh, Sedigheh, et al.
Publicado: (2022) -
Chronic histiocytic intervillositis (CHI): current treatments and perinatal outcomes, a systematic review and a meta-analysis
por: Moar, Laurel, et al.
Publicado: (2022) -
Molecular Pathology Demonstration of SARS-CoV-2 in Cytotrophoblast from Placental Tissue with Chronic Histiocytic Intervillositis, Trophoblast Necrosis and COVID-19
por: Schwartz, David A., et al.
Publicado: (2021)